Guidant to use CardioVascular's Focus technology:
This article was originally published in Clinica
Guidant's Vascular Intervention Group is to develop and market CardioVascular Dynamics' Focus technology in products designed to deliver Guidant's coronary and vascular stents. Guidant has exclusive rights to the technology for stent delivery in the US and Canada, and co-exclusive rights with CVD for the rest of the world. Irvine, California-based CVD will continue to sell the technology for balloon dilation procedures in the US and all applications elsewhere. Guidant will make payments to CVD, linked to the transfer of manufacturing technology and know-how, as well as royalties. CVD says its technology provides a unique method of performing coronary stent delivery using both low and high balloon inflation pressures on a single catheter.